Intravenous ferric derisomaltose for the treatment of iron deficiency anemia
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intravenous ferric derisomaltose for the treatment of iron deficiency anemia
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF HEMATOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-02-14
DOI
10.1002/ajh.26124
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia
- (2020) Myles Wolf et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Indirect methods of comparison of the safety of ferric derisomaltose, iron sucrose and ferric carboxymaltose in the treatment of iron deficiency anemia
- (2020) Richard F. Pollock et al. Expert Review of Hematology
- A 6 month extension trial evaluating safety and efficacy of ferric derisomaltose in patients with iron deficiency anemia: The FERWON‐EXT trial
- (2020) Maureen M. Achebe et al. AMERICAN JOURNAL OF HEMATOLOGY
- Clinical data for intravenous iron – debunking the hype around hypersensitivity
- (2020) Maureen Achebe et al. TRANSFUSION
- Safety of ferric derisomaltose and iron sucrose in patients with iron deficiency anemia: The FERWON‐IDA / NEPHRO trials
- (2020) Myles Wolf et al. AMERICAN JOURNAL OF HEMATOLOGY
- A prospective, multi‐center, randomized comparison of iron isomaltoside 1000 versus iron sucrose in patients with iron deficiency anemia; the FERWON‐IDA trial
- (2019) Michael Auerbach et al. AMERICAN JOURNAL OF HEMATOLOGY
- FGF23 at the crossroads of phosphate, iron economy and erythropoiesis
- (2019) Daniel Edmonston et al. Nature Reviews Nephrology
- NTBI Is Transiently Generated from Two Compartments during a Single Dose of Intravenous Iron - a Randomized Controlled Clinical Study
- (2019) Maciej W Garbowski et al. BLOOD
- The available intravenous iron formulations: History, efficacy, and toxicology
- (2017) Michael Auerbach et al. Hemodialysis International
- Complement Activation-Related Pseudo-Allergy: A Fresh Look at Hypersensitivity Reactions to Intravenous Iron
- (2016) Iain C. Macdougall et al. AMERICAN JOURNAL OF NEPHROLOGY
- Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials
- (2016) Ewa A. Jankowska et al. EUROPEAN JOURNAL OF HEART FAILURE
- Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management
- (2014) D. Rampton et al. HAEMATOLOGICA
- Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women
- (2013) Myles Wolf et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Structural characterization of iron oxide/hydroxide nanoparticles in nine different parenteral drugs for the treatment of iron deficiency anaemia by electron diffraction (ED) and X-ray powder diffraction (XRPD)
- (2013) S. Fütterer et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer®), a new intravenous iron preparation and its clinical implications
- (2011) Markus R. Jahn et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Diminished Quality of Life and Physical Function in Community-Dwelling Elderly With Anemia
- (2009) Mya Thein et al. MEDICINE
- The Comparative Safety of Intravenous Iron Dextran, Iron Saccharate, and Sodium Ferric Gluconate
- (2003) Steven Fishbane et al. SEMINARS IN DIALYSIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started